PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 194.00
-1.00 (-0.51%)
Apr 17, 2026, 3:30 PM JST
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 7.17 billion as of April 17, 2026. Its market cap has decreased by -32.90% in one year.
Market Cap
7.17B
Enterprise Value
4.34B
Revenue
684.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
194.00
Market Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 7.17B, a decrease of -59.84%. That is a compound annual growth rate of -39.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 7.17B | 24.42% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 8.78B |
| StemCell Institute | 8.03B |
| Carna Biosciences | 8.00B |
| MEDINET | 7.99B |
| CellSource | 7.76B |
| ADR120S | 7.37B |
| Chiome Bioscience | 7.30B |
| Kohjin Bio | 6.96B |